Title

An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN).

Document Type

Journal Article

Publication Date

5-1-2015

Journal

Journal of Neuro-oncology

Volume

123

Issue

1

Inclusive Pages

85-91

DOI

10.1007/s11060-015-1764-7

Comments

This is an open access PubMed Central article. Click on link for full-text access.

Peer Reviewed

1

Open Access

1